Clinical

Clinical  ·  Weekly Digest - 07 February to 13 February 2026
First patient dosed for a Phase 1b/2 clinical trial of PD-L1 ADC HLX43 combination therapy in advanced colorectal cancer

Weekly Digest – February 2026 Weekly Digest – February 2026 11 February 2026: First patient dosed for a Phase 1b/2 clinical trial of PD-L1 ADC HLX43 combination therapy in advanced colorectal cancer Shanghai Henlius Biotech announced that the first patient […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 07 February to 13 February 2026
Innovent dosed first participant in Phase 3 clinical study of IBI354 (novel HER2 ADC) for first line treatment of HER2-positive breast cancer

Weekly Digest – February 2026 Weekly Digest – February 2026 12 February 2026: Innovent dosed first participant in Phase 3 clinical study of IBI354 (novel HER2 ADC) for first line treatment of HER2-positive breast cancer Innovent Biologics announced that the […]

by Sandhya Ramalingam

Continue Reading